Inerma, UAB - financials and debts

Company age: 12 y. 2 mo.

Update

Inerma - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 18,362 24,218 26,183 23,372 25,623 38,422 42,686 41,000
Profit before tax -1,823 -4,133 -1,437 -6,562 -12,206 -23,829 -16,259 -13,906
Net profit -1,823 -4,133 -1,437 -6,562 -12,206 -23,829 -16,259 -13,906
Equity -9,788 -13,921 -15,358 -21,920 -34,126 -57,955 -74,214 -88,120
Liabilities 30,803 47,422 63,159 77,485 94,869 111,271 114,470 172,533
Non-current assets 681 1,582 2,064 2,515 1,705 896 238 946
Current assets 20,334 31,919 45,737 53,050 59,038 52,420 40,018 83,467
Total assets 21,015 33,501 47,801 55,565 60,743 53,316 40,256 84,413
Taxes paid
STI taxes - - - - - 7,065 8,481 8,774
Financial indicators
Revenue change y/y +29.0% +31.9% +8.1% -10.7% +9.6% +50.0% +11.1% -3.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -8.7% -12.3% -3.0% -11.8% -20.1% -44.7% -40.4% -16.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - - - - -
Profit margin Net profit margin. Shows the overall profitability of the company. -9.9% -17.1% -5.5% -28.1% -47.6% -62.0% -38.1% -33.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -9.9% -17.1% -5.5% -28.1% -47.6% -62.0% -38.1% -33.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - - - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 9,181 12,109 13,092 11,686 12,812 12,807 14,229 13,667

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Inerma - Social security debts

From To Debt, €
2026-07-23 2026-07-26 0.32
2026-07-19 2026-07-19 93.78
2026-07-16 2026-07-17 93.78
2026-06-16 2026-06-21 93.78
2026-05-17 2026-05-20 94.64
2026-05-03 2026-05-14 0.85
2026-04-24 2026-04-29 0.85
2026-04-20 2026-04-21 5.01
2026-01-16 2026-01-26 266.65
2025-07-16 2025-07-16 311.31
2025-05-16 2025-05-19 309.63
2025-01-16 2025-01-16 279.96
2024-07-16 2024-07-16 271.81
2024-05-16 2024-06-13 0.25
2024-04-23 2024-05-13 0.25
2024-04-16 2024-04-16 281.63
2024-02-19 2024-02-21 0.07
2024-01-23 2024-02-14 0.07
2023-08-17 2023-08-21 0.82
2023-07-28 2023-08-13 0.82
2023-07-24 2023-07-25 0.85
2023-06-16 2023-06-18 256.01
2023-05-16 2023-05-21 256.12
2023-05-02 2023-05-15 0.10
2023-04-26 2023-04-28 0.10
2023-03-16 2023-03-16 253.87
2022-11-21 2022-12-20 0.19
2022-11-17 2022-11-18 60.39
2022-10-28 2022-11-16 0.19
2022-10-18 2022-10-19 60.20
2022-09-16 2022-09-19 60.29
2022-07-25 2022-09-15 0.09
2022-07-18 2022-07-19 56.24
2022-05-17 2022-05-18 56.33
2022-04-28 2022-05-16 0.09
2022-03-16 2022-03-17 56.24
2022-01-31 2022-02-13 0.17
2022-01-18 2022-01-19 44.71
2021-12-16 2021-12-27 42.07
2021-11-16 2021-12-15 0.25
2021-11-05 2021-11-08 0.25
2021-09-16 2021-09-19 49.22

Inerma - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Inerma is: 788 €

From To Overdue, €
2026-09-01 2026-09-02 787.81
2026-08-31 2026-08-31 783.49
2026-08-28 2026-08-30 783.75
2026-08-02 2026-08-27 426.75
2026-07-26 2026-08-01 404.4
2026-07-01 2026-07-25 423.4
2026-06-30 2026-06-30 422.85
2026-06-28 2026-06-29 422.89
2026-06-01 2026-06-27 0.89
2026-05-31 2026-05-31 0.57
2026-05-01 2026-05-30 0.77
2026-04-30 2026-04-30 0.67
2026-04-01 2026-04-29 0.85
2026-03-29 2026-03-31 580.02
2026-03-20 2026-03-28 3.02
2026-03-11 2026-03-19 0.22
2026-03-02 2026-03-10 3.02
2026-02-27 2026-03-01 0.8
2026-02-03 2026-02-26 2.83
2026-01-31 2026-02-02 2.51
2026-01-01 2026-01-30 2.55
2025-12-01 2025-12-31 2.28
2025-11-28 2025-11-30 2.04
2025-11-25 2025-11-25 2.05
2025-11-02 2025-11-24 2.08
2025-10-25 2025-11-01 1.95
2025-10-02 2025-10-24 1.99
2025-09-28 2025-10-01 542.29
2025-09-03 2025-09-27 1.29
2025-09-01 2025-09-02 2.12
2025-08-31 2025-08-31 2.11
2025-08-16 2025-08-30 2.31
2025-08-01 2025-08-15 1.44
2025-07-30 2025-07-31 0.84
2025-07-28 2025-07-29 557.84
2025-07-18 2025-07-27 0.84
2025-07-17 2025-07-17 141.28
2025-07-16 2025-07-16 140.64
2025-07-02 2025-07-15 0.89
2025-07-01 2025-07-01 514.89
2025-06-28 2025-06-30 514.19
2025-06-25 2025-06-27 0.19
2025-06-16 2025-06-17 139.2
2025-05-01 2025-05-24 0.53
2025-04-30 2025-04-30 0.08
2025-04-28 2025-04-29 547.08
2025-04-26 2025-04-27 1.08
2025-04-14 2025-04-25 1.28
2025-04-09 2025-04-13 0.8
2025-04-08 2025-04-08 163.0
2025-04-06 2025-04-07 206.01
2025-04-04 2025-04-05 233.99
2025-04-02 2025-04-03 240.66
2025-03-31 2025-04-01 313.72
2025-03-28 2025-03-30 593.72
2024-12-30 2024-12-31 687.62

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Inerma, UAB (code 303340790) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of EUR 41.0K and recorded a net loss of EUR 13.9K, corresponding to a profit margin of -33.9%. Revenue declined by 4.0% year on year, but remained 6.7% above the 2023 level of EUR 38.4K, showing a modest two-year increase. Profitability improved gradually over the same period, with losses narrowing from EUR 23.8K in 2023 to EUR 16.3K in 2024 and EUR 13.9K in 2025. The balance sheet strengthened in asset size, with total assets rising to EUR 84.4K in 2025 from EUR 40.3K in 2024, while liabilities increased to EUR 172.5K. Equity remained negative and worsened to EUR -88.1K. Short-term assets accounted for most of the asset base, and asset turnover was 0.49x. Revenue per employee stood at EUR 13.7K in 2025, indicating limited operating scale.